4.7 Article

Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats

Journal

MOLECULAR MEDICINE
Volume 28, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1186/s10020-022-00566-6

Keywords

Adipose derived stem cells; hADSCs; Mesenchymal stem cells; MSCs; Hepatic fibrosis; Liver cirrhosis; Carbon tetrachloride

Funding

  1. Kanazawa Medical University [SR 2012-04]

Ask authors/readers for more resources

In this study, the effects of human adipose derived stem cells (hADSCs) on experimentally induced hepatic fibrosis and early cirrhosis in rats were evaluated. The results showed that treatment with hADSCs significantly improved liver functions and reduced hepatic fibrosis and early cirrhosis.
Background Mesenchymal stem cells (MSCs) are multipotent stromal cells and could exert hepatoprotective effects against acute liver injury, steatohepatitis, and fibrogenesis. Here, we evaluated the effects of human adipose derived stem cells (hADSCs) to attenuate experimentally induced hepatic fibrosis and early cirrhosis in rats. Methods Hepatic fibrosis was induced by intraperitoneal injections of CCl4 (0.1 ml/100 g body weight) twice a week for 8 weeks. hADSCs were isolated and cultured on polyethylene discs coated with hydroxyapatite and 2 cm diameter disc was surgically implanted on the right lateral lobe of the liver. Discs implanted without hADSCs served as control. The animals were injected again with CCl4 once a week for another 8 weeks. All the animals were sacrificed at the end of 16th week. Results Serial administrations of CCl4 resulted in well developed fibrosis and early cirrhosis at 8th week which maintained until the 16th week. Animals treated with hADSC discs depicted over 50% decrease of collagen with significant increase in serum albumin and total protein levels. Immunohistochemical staining for TGF-beta 1, alpha-smooth muscle actin, and collagen type I and type III demonstrated marked decrease compared to the animals without hADSC treatment. Conclusions Treatment with hADSCs improved liver functions, markedly reduced hepatic fibrosis and early cirrhosis. Various pleiotropic and paracrine factors secreted from the hADSCs seem to serve as reparative functions in the attenuation of liver cirrhosis. The data demonstrated that treatment with hADSCs can be successfully used as a potent therapeutic method to prevent progression of hepatic fibrosis and related adverse events.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available